Charles Schwab Investment Management Inc Ideaya Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$601 Billion
Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 715,538 shares of IDYA stock, worth $23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

715,538

Previous 716,798 0.18%

Holding current value

$23 Million

Previous $15.1 Million 29.22%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$21.12 - $27.21 $26,611 - $34,284	-1,260 Reduced 0.18%	715,538 $19.5 Million
Q2 2025 Aug 12, 2025	BUY	$14.5 - $22.63 $189,689 - $296,045	13,082 Added 1.86%	716,798 $15.1 Million
Q1 2025 Sep 15, 2025	SELL	$16.38 - $26.0 $214,283 - $340,132	-13,082 Reduced 1.83%	703,716 $11.5 Million
Q1 2025 May 09, 2025	SELL	$16.38 - $26.0 $148,976 - $236,470	-9,095 Reduced 1.28%	703,716 $11.5 Million
Q4 2024 Feb 06, 2025	BUY	$24.79 - $31.98 $588,465 - $759,141	23,738 Added 3.44%	712,811 $18.3 Million

Q3 2024 Nov 12, 2024	BUY	$30.37 - $43.05 $2.38 Million - $3.38 Million	78,518 Added 12.86%	689,073 $21.8 Million
Q2 2024 Aug 12, 2024	BUY	$34.37 - $43.46 $1.41 Million - $1.78 Million	40,966 Added 7.19%	610,555 $21.4 Million
Q1 2024 May 08, 2024	BUY	$34.2 - $47.13 $2.5 Million - $3.45 Million	73,133 Added 14.73%	569,589 $25 Million
Q4 2023 Feb 06, 2024	BUY	$24.59 - $35.83 $1.45 Million - $2.12 Million	59,100 Added 13.51%	496,456 $17.7 Million
Q3 2023 Nov 08, 2023	BUY	$21.07 - $29.77 $6.14 Million - $8.67 Million	291,240 Added 199.32%	437,356 $11.8 Million
Q2 2023 Aug 09, 2023	BUY	$13.33 - $25.53 $358,750 - $687,088	26,913 Added 22.58%	146,116 $3.43 Million
Q1 2023 May 11, 2023	BUY	$13.49 - $18.72 $14,366 - $19,936	1,065 Added 0.9%	119,203 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$14.47 - $18.17 $382,499 - $480,305	26,434 Added 28.83%	118,138 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $8,177 - $13,974	885 Added 0.97%	91,704 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $43,445 - $72,828	5,247 Added 6.13%	90,819 $1.25 Million
Q1 2022 May 13, 2022	BUY	$11.18 - $24.02 $23,578 - $50,658	2,109 Added 2.53%	85,572 $958,000
Q4 2021 Feb 11, 2022	BUY	$20.95 - $26.88 $5,824 - $7,472	278 Added 0.33%	83,463 $1.97 Million
Q3 2021 Nov 16, 2021	BUY	$17.26 - $27.08 $302,895 - $475,226	17,549 Added 26.74%	83,185 $2.12 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $387,416 - $541,641	21,814 Added 49.78%	65,636 $1.38 Million
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $62,196 - $109,674	4,614 Added 11.77%	43,822 $1.03 Million
Q3 2020 Nov 13, 2020	BUY	$11.22 - $14.46 $149,057 - $192,101	13,285 Added 51.25%	39,208 $493,000
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $93,063 - $481,390	25,923 New	25,923 $369,000

Others Institutions Holding IDYA

# of Institutions

238

Shares Held

82.1M

Call Options Held

509K

Put Options Held

103K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.54B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ideaya Biosciences, Inc. Transaction History